Dear colleagues,
Surprisingly, this discussion group has infrequently discussed the issues of big data, personalized medicine and precision medicine (-omics) despite overwhelming enthusiasm for this technology both by media and major funders.Big Data are famously introduced by its proponents as "death of theory"- all our inferences will be data driven only. EBM- traditionally extremely preoccupied with the ways we draw our inferences - strangely has remained silent, on the sideline of what appears to be introduction of a major disruptive technology in our life time.
Finally someone has written something about this- Gerd Antes of the German Cochrane Center, a frequent contributor to our discussion group, just wrote a thoughtful piece challenging this big data and -omics "revolution" from a classic methodological point of view. Here is the link to his piece:
>
>
> http://www.labtimes.org/editorial/e_654.lasso
>
> I hope Gerd's article stimulates some further discussion that perhaps will lead to more writing toward "EBM response to Big data and -omics"
Thanks
Ben djulbegovic
USF
>
>
>
|